1. CDK5 Activation Drives Pancreatic Neuroendocrine Tumorigenesis and is a Therapeutic Target. (2021) Authors: Carter, A.; Bibb, J.; Telange, R.; Howse, W.; Schrader, J.; Tan, C.; Robinson, B.; Reddy, S. Journal: HPB Issue: Volume 23(2021)Supplement 1 Page Start: S58 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗